Athene and Institutional Investors Commit €2.2 Billion in Support of Business Growth in European Guaranteed Life Insurance Market
AGER Bermuda Holding Ltd. (“AGER”), the holding company of Athene Holding Ltd.’s (“Athene”) German Group Companies, has received binding subscriptions for a capital raise that was conducted through a private placement of common equity securities. The offering received subscriptions representing €2.2 billion from Athene and a number of global institutional investors and is intended to support capital and reinsurance transactions in the German and European guaranteed life insurance market. The capital raised is permanent equity capital and does not include any financial leverage.
Athene will be a large minority shareholder in AGER, having committed up to €375 million in the offering. In addition, Athene expects to be a long-term strategic partner for AGER and will support its business in a number of different ways. As part of the long term partnership, Athene will be a preferred reinsurer for AGER’s spread liabilities.
“We see an unprecedented need in the German and broader European market for equity capital and reinsurance solutions to support run-off portfolios and closed block reinsurance transactions, particularly those with high guarantees,” said Deepak Rajan, Executive Vice President at AGER. “The closing of this capital commitment will allow us to complete transactions of significant scale across various European jurisdictions. We are delighted by the high quality nature of our investor base and believe this represents an industry solution to the issue of high cost legacy liabilities across Europe. Given the support of Athene, we believe that we are a highly credible counterparty for European insurers and provide them with the execution certainty they need.”
AGER’s strategy is to provide assistance to existing insurers by allowing them to free up capital, management capacities and operating resources through the sale or reinsurance of legacy portfolios or companies. AGER is a specialist in the run-off market and understands the unique needs of legacy companies and their policyholders. AGER is staffed to evaluate, structure, and complete large and complex transactions.
AGER is based in Bermuda, the second largest reinsurance market in the world. Bermuda is one of the first countries – among Switzerland and Japan – that has been granted full Solvency II equivalency by the European Commission. AGER’s principal operating subsidiary is Athene Lebensversicherung AG (“Athene Leben”), based in Germany. Athene Leben had €5 billion in invested assets as of 31 December 2016. Athene Leben has been in run-off since 2010 and since that time has developed the experience and efficiencies critical to succeed as a run-off specialist.
Ina Kirchhof, CEO of Athene Leben, added: “We are well-positioned to seize appropriate opportunities in the German and European run-off market with our core operating principles of policyholder protection as well as high quality asset and risk management. Policyholder satisfaction remains a top priority for us as we develop our company over the long term.”
The AGER offering is conditioned upon obtaining certain regulatory approvals, and other customary terms and conditions.
About AGER Bermuda Holding Ltd.
AGER, through its subsidiaries, is a specialist in the European life run-off market. The company works with insurers to monetize their legacy portfolios while expertly serving the needs of policyholders. The company’s principal operational subsidiary (Athene Leben) is located in Wiesbaden, Germany and it offers management services via its subsidiary in London, United Kingdom.
About Athene Lebensversicherung AG
Athene Leben is a Germany-based insurance company specialized in the efficient management of insurance portfolios in the areas of life, annuities and retirement planning. The company’s 200 employees efficiently manage and service approximately 300,000 contracts in Germany from its headquarters in Wiesbaden. Athene Leben is part of the Athene Deutschland group, which also includes Athene Pensionskasse AG, a specialist entity that offers customized retirement and survivor’s pensions under the occupational pension scheme.
In U.S., UK and Bermuda:
Athene Holding Ltd.
Karen Lynn, +1 441-279-8460 or +1 515-342-3910
Folker Dries, +49 69 921 874 26
Andrea Maibaum, +49 69 921 874 26
Investor Relations Contact
Athene Holding Ltd. (NYSE:ATH)
Paige Hart, +1 441-279-8527 or +1 310-698-4478
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13 | Pressemelding
Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21 | Pressemelding
Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38 | Pressemelding
A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00 | Pressemelding
Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a
AML BitCoin Enters Phase II of ICO15.12.2017 09:00 | Pressemelding
NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom